Mularoni A, Adessi G L, Arbez-Gindre F, Agnani G, Nicollier M
Service de Biochimie, Centre Hospitalier Universitaire, Besançon, France.
Clin Chem. 1996 Nov;42(11):1765-9.
Because the down-regulation by progesterone of cystic fibrosis transmembrane conductance regulator (CFTR) expression could be a useful specific marker to define the state of implant receptivity in endometrium, a competitive reverse transcription-polymerase chain reaction (RT-PCR) was developed for quantifying the CFTR mRNA concentration in human endometrial samples. A competitor RNA was constructed with the same sequence as the CFTR sequence except for a 20-nucleotide insertion in the middle. The amplified products were separated by polyacrylamide gel electrophoresis. The ratio of CFTR band areas to competitor band areas provided the basis of quantification. Using this competitive RT-PCR, we measured CFTR mRNA in human endometrial samples taken at different periods of the menstrual cycle, in endometriosis, and in hyperplasia. Results show that the method is suitable for measuring the concentration of CFTR mRNA.
由于孕酮对囊性纤维化跨膜传导调节因子(CFTR)表达的下调可能是定义子宫内膜着床接受性状态的有用特异性标志物,因此开发了一种竞争性逆转录聚合酶链反应(RT-PCR)来定量人子宫内膜样本中CFTR mRNA的浓度。构建了一种竞争RNA,其序列与CFTR序列相同,但中间插入了20个核苷酸。扩增产物通过聚丙烯酰胺凝胶电泳分离。CFTR条带面积与竞争条带面积的比值提供了定量的基础。使用这种竞争性RT-PCR,我们测量了在月经周期不同时期、子宫内膜异位症和增生症中采集的人子宫内膜样本中的CFTR mRNA。结果表明,该方法适用于测量CFTR mRNA的浓度。